Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR | Market Cap | 40.78B -29.9% |
| Revenue (ttm) | 23.30B +2.8% |
| Net Income | 2.12B +6.8% |
| EPS | 1.89 +7.0% |
| Shares Out | 1.12B |
| PE Ratio | 19.34 |
| Forward PE | 15.27 |
| Dividend | 1.00 (2.74%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 4,712,428 |
| Average Volume | 1,396,707 |
| Open | 37.22 |
| Previous Close | 36.99 |
| Day's Range | 36.51 - 37.38 |
| 52-Week Range | 36.51 - 53.04 |
| Beta | 0.80 |
| RSI | 23.74 |
| Earnings Date | May 7, 2026 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the readin... [Read more]
Financial Performance
In fiscal year 2025, Siemens Healthineers AG's revenue was 23.38 billion, an increase of 4.53% compared to the previous year's 22.36 billion. Earnings were 2.14 billion, an increase of 10.40%.
Financial StatementsNews
Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue
ORLANDO, Fla.--(BUSINESS WIRE)-- #Alzheimers--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions r...
EQS-AFR: Siemens Healthineers AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Siemens Healthineers AG / Preliminary announcement on the disclosure of financial statements Siemens Healthineers AG: Preliminary announcement of the pu...
EQS-DD: Siemens Healthineers AG: Dorothea Simon, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 20.03.2026 / 16:23 CET/CEST The issuer is solely responsi...
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use Brain-derived, fully automated Atellica IM P...
Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA
(RTTNews) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received FDA clearance. The companies sai...
Ki Reply and Data Reply Lay the Strategic Foundation for AI Innovation at Siemens Healthineers with “Cerebra”
TURIN, Italy--(BUSINESS WIRE)--Ki Reply and Data Reply, the Reply Group companies specialised respectively in AI-powered software development and data-driven solutions, have partnered with the “CRM Ex...
Siemens Healthineers Core Businesses Offset Currency, Tariff Challenges
Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff headwinds.
Siemens Healthineers beats Q1 profit estimates on strong imaging unit margins
Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin performance in its core imaging and cancer-care units helped cushion a slump in its...
5 European AI Stocks to Track in Q1 2026
While the artificial intelligence boom has continued to gather momentum in the United States and China, Europe's strengthening role in AI markets may be undervalued by investors, opening the door to f...
Siemens Healthineers preparing for potential Siemens's share sale -CFO
Siemens Healthineers is preparing for the possibility that its biggest shareholder Siemens AG may reduce its stake in the medical technology company to less than 50%, its CFO said on Wednesday.
Siemens Healthineers Reports Fall in Profits, Citing Tariffs
Higher comparable revenue stemming from the transformation program of its diagnostics business was offset by a hit from U.S. tariffs.
Siemens Healthineers slightly misses sales expectations in fourth quarter
Siemens Healthineers on Wednesday reported fourth-quarter revenue slightly below analysts' consensus as higher U.S. import tariffs weigh.
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #drugtesting--New drug testing analyzer helps identify substance use, monitor therapeutic and immunosuppressant drugs, and perform serum toxicology testing.
VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million
SAN DIEGO--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers...
EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen
Collaboration combines AI imaging, diagnostics expertise, and clinical leadership to drive digital pathology forward Collaboration combines AI imaging, diagnostics expertise, and clinical leadership t...
Carna Health and Siemens Healthineers join forces to Advance Kidney Care Innovation
BOSTON--(BUSINESS WIRE)--Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna's AI-enabled chro...
Siemens reduces stake in Siemens Healthineers to 71.12%
Siemens AG reduced its stake in medical technology company Siemens Healthineers by nearly 2 percentage points to 71.12%, according to a regulatory filing.
Siemens Healthineers meets Q3 sales expectations, raises guidance
German medical technology company Siemens Healthineers on Wednesday reported third-quarter revenue slightly above analysts' consensus, citing strong growth in its China business after declines last ye...
Siemens Healthineers Sets New Sustainability Benchmark as First IVD Manufacturer to Earn My Green Lab ACT Ecolabel for Analyzers, Reagents
TARRYTOWN, N.Y.--(BUSINESS WIRE)-- #healthcaredistribution--Siemens Healthineers has earned My Green Lab ACT Ecolabel Certification for more than 150 reagents used by medical laboratories for patient ...
Siemens Healthineers does not expect China restrictions to affect business
Siemens Healthineers does not expect the current developments in China to have a material impact on its business, a spokesperson for the German medical technology group said on Monday.
Siemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff Uncertainty
The healthcare-equipment company posted a rise in net profit and revenue for its fiscal second quarter but widened its adjusted earnings per share range on increased tariff uncertainty.
Siemens Healthineers posts revenue beat, but lowers floor of profit outlook
German medical technology group Siemens Healthineers posted second quarter revenue slightly above market expectations on Wednesday, but brought down the lower end of its annual earnings forecast due t...
Cardiovascular Image Fusion Software Market Analysis Report, 2025-2035, Featuring Ziehm Imaging, TeraRecon, OsiriX, Materialise, Siemens Healthineers and More
Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Image Fusion Software Market - A Global and Regional Analysis: Focus on Application, End User, and Country-Level Analysis - Analysis and Fo...
More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
PALO ALTO, Calif.--(BUSINESS WIRE)--Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025.
Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
Shenzhen, China--(Newsfile Corp. - February 28, 2025) - Recently, the world's first DSA-OCT integrated multi-modal diagnostic and treatment platform (ARTIS icono floor), jointly developed by Siemens H...